UPDATE: Goldman Sachs Downgrades Relmada Therapeutics Inc (RLMD) to Neutral
Tweet Send to a Friend
(Updated - October 28, 2020 4:52 AM EDT)
(updating comment)Goldman Sachs analyst Ross Weinreb downgraded Relmada Therapeutics Inc (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
(updating comment)Goldman Sachs analyst Ross Weinreb downgraded Relmada Therapeutics Inc (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
